Hemagen Diagnostics, Inc. (HMGN)

Hemagen Diagnostics Income Statement

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008
Period Ending	Sep 30, 2012	Sep 30, 2011	Sep 30, 2010	Sep 30, 2009	Sep 30, 2008
Revenue	4.04	5.14	5.22	5.42	6.37
Revenue Growth (YoY)	-21.38%	-1.51%	-3.67%	-14.99%	42.07%
Cost of Revenue	2.43	3.18	2.86	3.18	3.6
Gross Profit	1.61	1.96	2.36	2.23	2.77
Selling, General & Admin	2.01	2.43	2.1	2.33	2.51
Research & Development	0.04	0.01	0.03	0.09	0.15
Operating Expenses	2.05	2.43	2.12	2.42	2.65
Operating Income	-0.44	-0.47	0.24	-0.19	0.12
Interest Expense	-0.47	-0.41	-0.33	-0.4	-0.38
Other Non Operating Income (Expenses)	0	0	0	0	0.01
EBT Excluding Unusual Items	-0.91	-0.88	-0.09	-0.59	-0.24
Gain (Loss) on Sale of Assets	-0	0	0.03	0.04	-
Asset Writedown	-	-	-	-0.16	-
Pretax Income	-0.91	-0.88	-0.07	-0.71	-0.24
Income Tax Expense	-	0	0.09	0.02	0.13
Earnings From Continuing Operations	-0.91	-0.88	-0.16	-0.73	-0.37
Earnings From Discontinued Operations	-	-	-	-0.08	0.8
Net Income	-0.91	-0.88	-0.16	-0.81	0.43
Net Income to Common	-0.91	-0.88	-0.16	-0.81	0.43
Shares Outstanding (Basic)	15	15	15	15	15
Shares Outstanding (Diluted)	15	15	15	15	15
Shares Change (YoY)	0.13%	0.14%	1.44%	0.03%	0.03%
EPS (Basic)	-0.06	-0.06	-0.01	-0.05	0.03
EPS (Diluted)	-0.06	-0.06	-0.01	-0.06	0.03
Free Cash Flow	-0.45	-0.39	-0.26	-0.1	-0.1
Free Cash Flow Per Share	-0.03	-0.03	-0.02	-0.01	-0.01
Gross Margin	39.92%	38.14%	45.14%	41.23%	43.49%
Operating Margin	-10.83%	-9.20%	4.52%	-3.45%	1.85%
Profit Margin	-22.45%	-17.13%	-2.99%	-14.91%	6.70%
Free Cash Flow Margin	-11.13%	-7.66%	-4.93%	-1.81%	-1.62%
EBITDA	-0.27	-0.29	0.4	-0.03	0.23
EBITDA Margin	-6.77%	-5.58%	7.66%	-0.55%	3.54%
D&A For EBITDA	0.16	0.19	0.16	0.16	0.11
EBIT	-0.44	-0.47	0.24	-0.19	0.12
EBIT Margin	-10.83%	-9.20%	4.52%	-3.45%	1.85%
Advertising Expenses	0.01	0.01	0.01	0.02	0.02

Source: S&P Global Market Intelligence. Standard template. Financial Sources.